Compare · GOOG vs TEM
GOOG vs TEM
Side-by-side comparison of Alphabet Inc. (GOOG) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GOOG and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- GOOG is the larger of the two at $4.20T, about 338.8x TEM ($12.40B).
- Over the past year, GOOG is up 33.9% and TEM is down 28.0% - GOOG leads by 61.9 points.
- TEM has been more active in the news (11 items in the past 4 weeks vs 1 for GOOG).
- Both have 25 recent analyst ratings on file.
- Company
- Alphabet Inc.
- Tempus AI Inc.
- Price
- $337.21-2.22%
- $65.48-7.96%
- Market cap
- $4.20T
- $12.40B
- 1M return
- -1.89%
- -18.43%
- 1Y return
- +33.90%
- -28.04%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2004
- 2024
- News (4w)
- 1
- 11
- Recent ratings
- 25
- 25
Alphabet Inc.
Alphabet Inc. provides online advertising services in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. The company offers performance and brand advertising services. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, such as ads, Android, Chrome, hardware, Google Maps, Google Play, Search, and YouTube, as well as technical infrastructure; and digital content. The Google Cloud segment offers infrastructure and data analytics platforms, collaboration tools, and other services for enterprise customers. The Other Bets segment sells internet and TV services, as well as licensing and research and development services. The company was founded in 1998 and is headquartered in Mountain View, California.
Latest GOOG
- Contracted Capacity Becomes Key Metric for AI Infrastructure Investors to Watch
- Rosenblatt resumed coverage on Alphabet
- UBS reiterated coverage on Alphabet with a new price target
- BMO Capital Markets reiterated coverage on Alphabet with a new price target
- Truist reiterated coverage on Alphabet with a new price target
- Cantor Fitzgerald reiterated coverage on Alphabet with a new price target
- Roth Capital reiterated coverage on Alphabet with a new price target
- DA Davidson reiterated coverage on Alphabet with a new price target
- Barclays reiterated coverage on Alphabet with a new price target
- Wells Fargo reiterated coverage on Alphabet with a new price target
Latest TEM
- Tempus to Report Third Quarter 2026 Financial Results on November 2
- Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Amendment: SEC Form S-4/A filed by Tempus AI Inc.
- Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- CEO, Diagnostics Schoenherr Thomas Edward sold $873,885 worth of shares (10,281 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 76,740 units (SEC Form 4)
- Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
- CEO and Chairman Lefkofsky Eric P sold $19,366,630 worth of shares (250,000 units at $77.47) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Tempus AI Inc.
- Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model